Biocon

Notification to Stock Exchanges

05 Dec, 2025 | 06:00pm • Source: BSE

Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)

05 Dec, 2025 | 03:42pm • Source: BSE

Biocon Limited has informed the Exchange regarding a press release dated December 02, 2025, titled "Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in...

02 Dec, 2025 | 09:47am • Source: NSE

Press Release

02 Dec, 2025 | 09:10am • Source: BSE

Biocon Limited has informed the Exchange regarding Company Statement.

27 Nov, 2025 | 10:28am • Source: NSE

Company Statement

27 Nov, 2025 | 08:25am • Source: BSE

Notification

19 Nov, 2025 | 09:06am • Source: BSE

Rumour verification

14 Nov, 2025 | 08:35am • Source: BSE

Audio and Video Recording of Q2 FY26 Earnings Call

12 Nov, 2025 | 03:17pm • Source: BSE

Investor Presentation

12 Nov, 2025 | 08:36am • Source: BSE

Monitoring Agency report

11 Nov, 2025 | 08:58pm • Source: BSE

Outcome of Board meeting _ Raising of funds through issuance of commercial papers

11 Nov, 2025 | 08:54pm • Source: BSE

Press Release

11 Nov, 2025 | 08:51pm • Source: BSE

Outcome of Board Meeting _ Acquisition of Compulsory Convertible Debentures.

11 Nov, 2025 | 08:49pm • Source: BSE

Outcome of Board Meeting _ Early full redemption of Non-Convertible Debentures

11 Nov, 2025 | 08:42pm • Source: BSE

Outcome of Board meeting held on November 11, 2025

11 Nov, 2025 | 08:38pm • Source: BSE

Outcome of Board Meeting held on November 11, 2025

11 Nov, 2025 | 08:32pm • Source: BSE

Financial results for Quarter and Half year ended 30 September, 2025

11 Nov, 2025 | 08:29pm • Source: BSE

Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve...

06 Nov, 2025 | 05:42pm • Source: BSE

Intimation for Earnings Conference Call for analysts/investors for Q2 FY 2025-26 Financial Results

04 Nov, 2025 | 03:03pm • Source: BSE